Damon Runyon Cancer Research Foundation award to Dr. Mancias
January 24, 2019
Dr. Mancias received a Damon Runyon Research Foundation award. Read the story.
News
Dr. Dougan cited in the 2018 PanCAN annual report
December 18, 2018
Dr. Dougan was cited in the PanCAN 2018 annual report. Read the story.
PanCAN investigator spotlight: Stephanie Dougan, PhD
November 26, 2018
Dr. Dougan was featured in an article, since she is a recipient of a research grant from Pancreatic Cancer Action Network (PanCAN). Read the story.
Pancreatic Cancer Collective awards Dana-Farber Cancer Institute researchers “New Therapies Challenge” grant
November 20, 2018
The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded Drs. Alan D’Andrea and James Cleary $1 million in initial funding to evaluate DNA repair inhibitors in pancreatic cancer. Read the story. Announcement from Lustgarten foundation
PanCAN investigator spotlight: Andrew Aguirre, MD, PhD
November 19, 2018
Dr. Aguirre was featured in a recent article, since he is a recipient of a research grant from Pancreatic Cancer Action Network (PanCAN). Read the story.
New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients
November 14, 2018
“Although there have been incredible leaps in the entire field of genetics, getting everyone on board with genetic testing isn’t the same thing as getting everyone on board with trying new drugs, which is a lot easier,” says gastrointestinal cancer genetics and prevention expert Dr. Sapna Syngal. “But solid steps…
Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Center for Protein Degradation
November 13, 2018
Dana-Farber Cancer Institute and Deerfield Management announced today an up to $80 million collaboration to create the Center for Protein Degradation at Dana-Farber. The goal of the Center for Protein Degradation is to interrogate and advance a large portfolio of advanced targeted protein degrader targets while creating a next-generation protein…
BRCA2 and Pancreatic Cancer: What’s the Connection?
November 3, 2018
Pancreatic cancer is notorious for being difficult to treat—and it is often not detected until it advances beyond the pancreas. While smoking and obesity are two established risk factors that impact this disease, another risk factor can be mutations in the BRCA2 gene, also associated with breast and ovarian cancer.…
Lustgarten Foundation Advances Pancreatic Cancer Research Through Partnerships with the Opening of Two New Laboratories
September 21, 2018
The Lustgarten Foundation is pleased to announce two new pancreatic cancer research laboratories through respective partnerships with Dana-Farber Cancer Institute and Massachusetts Institute of Technology (MIT). The opening of these Lustgarten Foundation Pancreatic Cancer Research Laboratories will usher in a new era of research progress and represents an initial $10…
Study resolves decades-old mystery about the most commonly mutated gene in cancer
September 17, 2018
The most commonly mutated gene in cancer has tantalized scientists for decades about the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency at a handful of points dubbed “hot spots.” Does this imbalance suggest that hotspot mutations…